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Background: Microorganisms use two-component signal transduction (TCST) systems to regulate the response of
the organism to changes of environmental conditions. Such systems are absent from mammalian cells and are thus
of interest as drug targets. Fungal TCST systems are usually composed of a hybrid histidine kinase, comprising the
histidine kinase (HisKA) domain and a receiver domain, a histidine phosphotransfer protein and a response
regulator. Among the 11 groups of fungal histidine kinases, group III histidine kinases are of particular relevance as
they are essential for the activity of different groups of fungicides. A characteristic feature is the N-terminal amino
acid repeat domain comprising multiple HAMP domains, of which the function is still largely unknown. In Candida
albicans, a fungal human pathogen, three histidine kinases were identified, of which CaNik1p is a group III histidine
kinase. Heterologous expression of this protein in Sacchromyces cerevisiae conferred susceptibility to different
fungicides. Fungicide activity was associated with phosphorylation of the mitogen activated protein kinase Hog1p.
Results: We have constructed mutated versions of CaNik1p, from which either all HAMP domains were deleted
(CaNik1pΔHAMP) or in which the histidine kinase or the receiver domains were not-functional. Expression of
CaNIK1ΔHAMP in S. cerevisiae led to severe growth inhibition. Normal growth could be restored by either replacing
the phosphate-accepting histidine residue in CaNik1pΔHAMP or by expressing CaNIK1ΔHAMP in S. cerevisiae
mutants, in which single genes encoding several components of the HOG pathway were deleted. Expression of
proteins with non-functional histidine kinase or receiver domains resulted in complete loss of susceptibility to
antifungals, such as fludioxonil. Conditions leading to growth inhibition of transformants also led to
phosphorylation of the MAP kinase Hog1p.
Conclusion: Our results show that functional histidine kinase and receiver domains of CaNik1p were essential for
antifungal susceptibility and for activation of the Hog1p. Moreover, for the first time we show that deletion of all
HAMP domains from CaNik1p led to activation of Hog1p without an external stimulus. This phenotype was similar
to the effects obtained upon treatment with fungicides, as in both cases growth inhibition correlated with Hog1p
activation and was dependent on the functionality of the conserved phosphate-accepting histidine residue.
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Figure 1 Schematic representation of the role of different
domains of CaNik1p for the protein activity. ATP binds to the
HATPase_c domain, and a phosphate group is first transferred to the
conserved phosphate accepting residue His510 of the HisKA domain
and then to Asp924 of the REC domain.
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Immune-compromised patients are at high risk of becom-
ing infected by opportunistic fungi, such as Candida and
Aspergillus sp. Candida sp. are the fourth most frequent
cause of hospital acquired blood stream infections and up
to 90% of HIV patients receive mucosal candidiasis at least
once [1]. Although infections with non-albicans Candida
sp. have emerged in recent years [2], the species C. albicans
is still responsible for the majority of the cases [3,4].
Several antifungals are available in the market, yet, tox-
icity and/or development of resistance represent major
concerns [5]. Among these is the former “gold standard”
therapeutic amphotericin B that invariably causes toxicity
in patients, negating the importance of its fungicidal activ-
ity. Although azoles and echinocandins represent the most
widely used treatments of candidiasis, the acquisition of re-
sistance can occur, leading to the risk of recurrent infec-
tions [6,7]. Thus antifungals which impact new targets and
have minimal side effects are urgently needed [7].
In fungi, two-component signal transduction (TCST)
systems have been implicated in osmotic and oxidative
stress responses, cell-cycle control, red/far-red light re-
sponses, and virulence switches from non-pathogenic to
pathogenic states [8-10]. Since TCST systems are absent
in mammalian cells, they are attractive targets for the
development of new antifungals with probably minimal
side effects in humans [7].
Typical TCST systems in fungi include a histidine kin-
ase (HK), a histidine phosphotransfer protein (HPT) and
a response regulator protein (RR). The best understood
fungal TCST system is part of the High Osmolarity Gly-
cerol (HOG) pathway in S. cerevisiae. In the absence of
osmotic stress, the transmembrane HK ScSln1p is active.
This HK activity leads to phosphorylation of a histidine
residue in the catalytic domain, the so-called HisKA do-
main, from which the phosphate group is transferred to
an aspartic acid residue in an internal receiver domain
(REC). Therefore, these HKs are called hybrid HKs. The
phosphate group is then shuttled through the HPT pro-
tein Ypd1p to the terminal RR proteins Skn7p and Ssk1p
[8,11]. Phosphorylated Skn7p is a direct regulator of gene
expression, whereas phosphorylated Ssk1p is not able to
activate downstream targets. Under conditions of high
osmolarity, ScSln1p is inactive, resulting in the dephos-
phorylation of both RRs. Unphosphorylated Skn7p be-
comes inactive, whereas unphosphorylated Ssk1p activates
a downstream mitogen-activated protein kinase (MAPK)
module, in particular the MAP3K Ssk2p resulting in phos-
phorylation of the MAPK Hog1p [7,12-15]. Phosphory-
lated Hog1p upregulates the transcription of genes, which
encode enzymes that play a key role in glycerol production
and maintenance of the intracellular water balance,
allowing adaptation to high-osmolarity conditions [13].
Thus, the HK ScSln1p is a negative regulator of theMAPK Hog1p. Likewise, disruption of ScSLN1 results in
the accumulation of unphosphorylated Ssk1p without ex-
ternal stimulus and thus, constitutive activation of Hog1p,
which is lethal [14].
While S. cerevisiae has a single HK, namely ScSln1p, C.
albicans has three HKs: CaSln1p, CaNik1p (also called
Cos1) and Chk1p [8]. CaNik1p is considered to be a cyto-
solic enzyme, as it lacks the hydrophobic amino acids indi-
cative of membrane-spanning domains (Figure 1) [16]. The
protein is not essential for survival, and a gene deletion
mutant could be generated [16-18]. CaNik1p plays an im-
portant role in hyphal formation in C. albicans on solid
media [8,18]. Additionally, the deletion mutant was found
to be less virulent in a mouse model for systemic candidia-
sis [8]. According to the classification scheme of HKs [9],
ScSln1p and CaSln1p are group VI HKs while CaNik1p is
a group III HK.
Several chemical classes of fungicides, such as phen-
ylpyrroles (fludioxonil), dicarboximides (iprodione) and
polyketide secondary metabolites of ambruticins, exert
their antifungal effects by activating the HOG signaling
pathway, resulting in the accumulation of both glycerol
and free fatty acids [19-22]. It is assumed that in the ab-
sence of high external osmolarity, artificial induction of
excess intracellular glycerol causes leakage of cellular con-
tents and ultimately results in cell death [21,22]. Mutations
in group III HKs are frequently associated with fungicide
resistance [19], showing the relevance of these enzymes for
fungicide activity and placing also these HKs upstream the
MAPK Hog1p. It is still discussed, whether group III HKs
are negative (as is ScSln1p) [23] or positive [24] regulators
of Hog1p. S. cerevisiae lacks group III HKs and is usually
resistant to the fungicides mentioned above. However, fun-
gicidal sensitivity is gained by heterologous functional ex-
pression of group III HKs in S. cerevisiae correlating with
Hog1p phosphorylation [25-28].
All classes of HKs share the conserved phosphate-
accepting domains HisKA, REC and an ATP-binding
El-Mowafy et al. BMC Microbiology 2013, 13:209 Page 3 of 12
http://www.biomedcentral.com/1471-2180/13/209domain called HATPase_c domain. Based on homology
with other HKs, the histidine residue 510 and the aspartate
residue 924 in CaNik1p were identified as the essential
phosphorylatable residues for the HisKA and the REC do-
mains respectively (Figure 1) [17]. The ATP-binding do-
main comprises a characteristic N-box with two asparagine
residues, which are N623 and N627 in CaNik1p [17]. The
N-box is known to be essential for ATP binding [29] and
deletion of a single asparagine residue was associated with
complete inhibition of ATP binding in the HK EnvZ [30].
Group III HKs are characterized by additional amino
acid repeats in the N-terminal part with a length of ap-
proximately 90 amino acids each. The repeats contain
evolutionary conserved amino acid sequences called
HAMP domains. Such abbreviation is due to the fre-
quent occurrence of such domains in histidine kinases,
adenylcyclases, methyl accepting chemotaxis proteins
and phosphatases, which are proteins associated with
signal transduction in both prokaryotic and lower
eukaryotic organisms [31]. More than 26400 proteins
with HAMP domains exist in the SMART data base.
These domains were shown to play an active role in
intramolecular signal transduction in prokaryotic sensor
kinases. They are composed of about 50 amino acid res-
idues each with two amphipathic helices [32-34] which
probably rotate when the sensor domain of the protein
is activated as recently elucidated from NMR analysis
[35,36]. Unlike the bacterial HK, which usually possess
a single HAMP domain, fungal group III HKs have sev-
eral consecutive HAMP domains. In the five N-terminal
amino acid repeats of CaNik1p [16-18] we identified
nine HAMP domains of a concatenated structure
forming four pairs each with an overall length of 92
amino acids and a single HAMP domain in the
remaining truncated amino acid repeat [25].
To study the role of the various protein domains in
the function of group III HKs different protein mutants
were constructed. In Hik1p, a group III HK from
Magnaporthe grisea, phosphate acceptance on both the
conserved histidine and aspartic acid residues in the cata-
lytic and the receiver domains respectively was essential
for the susceptibility to phenylpyrroles and ambruticin
VS4 [26,27]. Deletions of single pairs of HAMP domains
from the HK CaNik1p of C. albicans were associated with
decreased susceptibility to fungicides, showing the rele-
vance of these domains for fungicide activity [25] and de-
letion of four out of five amino acid repeats from the HK
DhNik1p of Dabaryomyces hansenii generated a constitu-
tively active HK, which was resistant to osmotic stress and
fungicide treatment [23,37].
As C. albicans is a human pathogen, understanding
the relevance of the N-terminal nine HAMP domains
and of the HisKA, HATPase_c and REC domains of
CaNik1p for the action of antifungal compounds canguide development of new antimycotic strategies. To
achieve this goal, point mutations were introduced in
the HisKA, HATPase_c and REC domains of CaNIK1
which should render these domains non-functional. In
addition, a deletion mutant for all HAMP domains was
generated. Due to the ease of genetic manipulation of S.
cerevisiae the plasmids harboring the mutated CaNIK1
were used to transform S. cerevisiae followed by testing
viability, sensitivity to fungicides and phosphorylation of
the MAPK Hog1p upon fungicidal treatment.
Methods
Organisms and growth conditions
S. cerevisiae BWG1-7a [38] and BY4741 [39] were used
in the present study (Table 1).
Prior to transformation, S. cerevisiae was grown in
YPD medium (Sigma-Aldrich) at 30°C. S. cerevisiae
transformants were selected and maintained in SD-ura
(according to [40]), at 30°C. To obtain high cell density
before induction of transgene expression, the trans-
formants were cultivated at 30°C in SD-ura for 36 h. To
induce transgene expression from the 36 h SD-ura cul-
ture, an overnight culture, a preculture (2–3 h) and ul-
timately a working culture were prepared in SG-ura.
For growth of the reference S. cerevisiae strain uracil
was added at a concentration of 40 mg/l.
Solidified media were prepared by addition of 1.5%
bacto agar (Difco).
E. coli XL1-Blue growth, transformation and plasmid
DNA preparation were performed using standard methods
according to the manufacturer’s instructions.
Mutagenesis of the cloned CaNIK1 gene in the pYES2
plasmid and expression of the mutated constructs in S.
Cerevisiae transformants:
The plasmid pYES2-CaNIK1-TAG [25] was used as a tem-
plate for all the generated mutants in the present work. It
encodes the wild-type CaNik1p protein fused to a HIS/
FLAG tag at the C- terminus. Point mutations were intro-
duced in the HisKA (H510Q), HATPase_c (N627D) and
REC (D924N) domains using the quick-change site-
directed mutagenesis kit (Stratagene). The nucleotide se-
quences of the primers used, where the nucleotide
changes were introduced to lead to the desired mutations,
are given in Table 2. The PCR reaction mixture, the ampli-
fication program, the digestion with the restriction enzyme
DpnI (Stratagene) and the transformation of the compe-
tent cells were carried out according to the manufacturer’s
instructions.
In CaNik1p (1081 aa), all the HAMP domains (63–485
aa) were deleted using the in-fusion HD cloning kit
(Clontech). Briefly, the in-fusion enzyme is able to fuse
up to four DNA fragments with a linearized vector upon
recognizing 15 bp overlapping sequences at their ends.
Table 1 S. cerevisiae strains used in this study
Strain designation Genotype Transformed with Reference
BWG1-7a Mat a ura3-52 leu2-3,112 his4-519 ade1-100 - [38]
YES BWG1-7a pYES2 This study
NIK BWG1-7a pYES2-CaNIK1-TAG [25]
H510 BWG1-7a pYES2-CaNIK1(H510Q) This study
D924 BWG1-7a pYES2-CaNIK1(D924N) This study
N627 BWG1-7a pYES2-CaNIK1(N627D) This study
ΔHa BWG1-7a pYES2-CaNIK1ΔHAMP This study
ΔHaH510 BWG1-7a pYES2-CaNIK1ΔHAMP(H510Q) This study
ΔH3H4 BWG1-7a pYES2-CaNIK1Δ224-315Δ327-418aa [27]
BY4741 Mat a his3Δ 1; leu2Δ 0; met15Δ 0; ura3Δ 0 - [39]
ΔHb BY4741 pYES2-CaNIK1ΔHAMP This study
ΔHbH510 BY4741 pYES2-CaNIK1ΔHAMP(H510Q) This study
Δssk1 BY4741, YLR006c::kanMX4 - [49]
Δpbs2 BY4741, YJL128c::kanMX4 - [49]
Δhog BY4741, YLR113w::kanMX4 - [49]
ΔHbΔssk1 Δssk1 pYES2-CaNIK1ΔHAMP This study
ΔHbΔpbs2 Δpbs2 pYES2-CaNIK1ΔHAMP This study
ΔHbΔhog Δhog pYES2-CaNIK1ΔHAMP This study
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to the primers which were used to amplify the target
fragments.
The pYES2 vector was linearized using the restriction en-
zyme HindIII and the pYES-CaNIK1-TAG vector was used
as a template for amplification of the gene fragments. The
sequence of CaNIK1 upstream of the fragment encoding
the HAMP domains (1–186 bp) was amplified using the
HMPF1 and HMPR1 primers (Table 2). HMPF1 included
homologous 15 bp with the end of the linearized vector
downstream of the galactose promoter. The CaNIK1 frag-
ment located downstream the sequence encoding the












Bold bases are those used to introduce the point mutations. Bold italic bases indica
recognized by the in-fusion enzyme.(1454–3243 bp) was amplified using the HMPF2 and
HMPR2 primers (Table 2). HMPF2 and HMPR2 shared
15 bp homologous stretches with the 172–186 bp frag-
ment of CaNIK1 and with the other end of the HindIII-
linearized pYES2 vector, respectively. HindIII restriction
sites were introduced into the sequences of the HMPF1
and HMPR2 primers. After separation of the PCR amp-
lified fragments by electrophoresis on 1.2% agarose gels,
the gel pieces carrying the amplification products were
excised and the DNA was purified using a gel extraction
kit (Qiagen). The purified fragments were ligated into
the digested pYES2 vector using the in-fusion enzyme
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ther confirmed by sequencing the generated constructs
(Dept. GNA, HZI, Braunschweig) using primers span-
ning the target fragments. The mutated constructs were
used to transform S. cerevisiae using the lithium acetate
method [40]. Transformants (Table 1) were selected on
SD-ura agar plates.
Susceptibility assays
In 96 well microtiter plates, working cultures of the
transformants were incubated in 180 μl SG-ura supp-
lemented with the appropriate concentrations of the anti-
fungals in triplicates for 24 h. The starting OD at 620 nm
was 0.03 and measured using a μQuant scanning mic-
roplate spectrophotometer (Biotek). To detect growth
inhibitory effects, the OD620nm was again measured after
24 h. The antifungals fludioxonil and iprodione were
obtained from Fluka, whereas ambruticin VS3 was pro-
duced as described and kindly provided by K. Gerth and
R. Jansen (HZI, Braunschweig) [41].
Detection of Hog1p phosphorylation
Phosphorylation of the MAPK Hog1 was investigated in
transformants with CaNIK1 carrying point mutations as
previously described [25]. Briefly, from precultures in
SG-ura working cultures of the transformants were pre-
pared in SG-ura containing 10 μg/ml fludioxonil with a
starting OD620nm of 0.2. Cells were harvested 15 min
after the start of the working culture by centrifugation.
Sorbitol (1 M) was used as a positive control, as it is
known to stimulate phosphorylation of the MAPK
Hog1p via the induction of osmotic stress [42].
To avoid Hog1 phosphorylation caused by cold stress
[43], cells were directly shock frozen in liquid nitrogen
after centrifugation. Frozen cell pellets were mechanic-
ally disrupted by grinding with the mini-dismembrator
U (B. Braun Biotech, Melsungen, Germany) in the pres-
ence of lysis buffer (10 mM sodium phosphate buffer
pH 7, supplemented with 5 mM NaCl, 5 mM KCl, pro-
tease and phosphatase inhibitors (cOmplete ULTRA,
mini, EDTA free and PhosSTOP (Roche)). Protein con-
centrations of the supernatants were determined using
the BCA assay [44].
A total of 5 μg protein per sample was separated by
SDS-PAGE (12.5%) and proteins were blotted onto a
PVDF membrane. Phosphorylated Hog1 was detected
using the combination of an anti-phospho p38 MAPK
(Thr180/182) 3D7 rabbit monoclonal antibody (Cell
Signaling Technology) with an HRP-conjugated anti-
rabbit IgG (Cell Signaling Technology) as secondary
antibody. Incubation of the antibodies was followed
by the addition of a peroxidase-specific chemiluminescence
substrate (ECL; Advance Western Blotting Detection Kit,
GE Healthcare). The bound antibodies were removed bytreatment with 1xRe-Blot Plus Solution (Millipore) and
subsequently total Hog1p was detected using anti-Hog1
(y-215) sc-9079 rabbit polyclonal IgG (Santa Cruz Bio-
technology) and the above mentioned secondary anti-
body followed by visualization with the ECL substrate.
Detection of phosphorylation of Hog1p in S. cerevisiae
transformed with CaNIK1pΔHAMP
Due to the growth inhibitory effect resulting from the
expression of CaNik1pΔHAMP in the ΔHa strain, phos-
phorylation of Hog1p was investigated at an early time
point after inducing the expression of CaNik1pΔHAMP.
Therefore ΔHa was first cultivated in SD-ura until
OD620nm = 1. Cells were harvested by centrifugation and
transferred to SG-ura (starting OD620nm = 0.2). After in-
cubation at 30°C for 195 and 210 min, samples were
centrifuged and treated as previously mentioned for the
detection of Hog1p phosphorylation by Western blot-
ting. Fludioxonil was added as an inducer of Hog1
phosphorylation (positive control) after 180 min at a
final concentration of 10 μg/ml.
To confirm the expression of CaNik1pΔHAMP, ΔHa
cells were harvested after 180 min incubation in SG-ura,
disrupted and the FLAG-tagged protein was detected
using a HRP-conjugated monoclonal anti-FLAG anti-
body (Sigma-Aldrich).
Results
The conserved domains of CaNik1p were essential for the
susceptibility of S. cerevisiae transformants to antifungals
After alignment with other HKs, in CaNik1p histidine 510
and aspartate 924 were identified as the essential residues
for the HisKA and the REC domains respectively [17]
and asparagine 627 for the N-box of the ATP-binding do-
main. Hence, to inhibit the conserved phosphorylation re-
actions within CaNik1p, mutant genes were generated, in
which either Asn627 from the HATPase_c domain was
substituted by aspartate (N627D), His510 by glutamine
(H510Q) or Asp924 by asparagine (D924N). S. cerevisiae
was transformed with the plasmids carrying the mutated
CaNIK1 genes, and the resultant transformants were
treated with the antifungals fludioxonil, iprodione and
ambruticin VS3. As shown in Figure 2, the strain YES
transformed with the empty vector was resistant to all fun-
gicides, while the strain NIK was susceptible to the studied
antifungals. The H510Q and D924N point mutations in
the HisKA and REC domains respectively, led to complete
loss of susceptibility, while the N627D substitution in the
HATPase_c domain only decreased the susceptibility to
the fungicides in comparison to the strain NIK.
His510 and Asp924 are the conserved phosphate-
accepting residues in the HisKA and the REC domains,
respectively, which are required for kinase function of
hybrid HKs. They are phosphorylated by the histidine
Figure 2 The conserved domains of CaNik1p were essential for the susceptibility to the fungicides. The phenylpyrrole fludioxonil, the
dicarboximide iprodione and the myxobacterial secondary metabolite ambruticin VS3 were used as representative antifungal compounds
targeting fungal group III histidine kinases. Error bars represent the standard deviation from three independent experiments.
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phosphate-transfer to the REC domain within the same
protein (Asp924). Loss of fungicide susceptibility of the re-
spective mutants suggested that the functionality of both
the HisKA and the REC domain was essential for the anti-
fungal activity.
Probably the N627D mutation did not completely pre-
vent ATP binding to the HATPase_c domain and as a
result only a partial effect was obtained.Functional HisKA, HATPase_c and REC domains were
essential for the phosphorylation of Hog1p after
fludioxonil treatment
Treatment with fludioxonil led to phosphorylation of
the MAPK Hog1p, i.e. to the activation of the HOG path-
way, in S. cerevisiae transformed with full-length and trun-
cated forms of CaNIK1 [25]. Therefore, phosphorylation of
Hog1p was also analyzed after fludioxonil-treatment of S.
cerevisiae transformed with CaNIK1 carrying the H510Q,
N627D and D924N point mutations. Phosphorylation of
the protein was totally abolished in the mutant strains
D924 and H510, while phosphorylation of Hog1p in strain
N627 was decreased but not totally inhibited (Figure 3).
Thus, activation of Hog1p correlated with the inhibition of
the yeast’s growth by fludioxonil and both effects required
the functionality of the domains that are essential for thehistidine kinase function of the protein, which involves
phosphorylation of both His510 and Asp924 of CaNik1p.
Since high concentrations of sorbitol activate the
HOG pathway via inhibition of the HK Sln1p, treat-
ment of the transformants with 1 M sorbitol was used
as a positive control.
Normal growth of the yeast was inhibited upon
expression of CaNik1pΔHAMP and was restored by
inhibition of the HOG pathway
Previous work had shown that deletion of single and
double pairs of HAMP domains of CaNik1p affected the
susceptibility of the resultant mutants to the fungicides
[25], and for the HK DhNik1 it was described that dele-
tion of four out of five amino acid repeats generated a con-
stitutively active HK, which could not be inhibited by
fludioxonil [23]. Thus we decided to delete all HAMP do-
mains from CaNIK1p. Transforming S. cerevisiae with a
plasmid carrying a truncated version of CaNIK1, in which
all HAMP domains were deleted from the protein, resulted
in the ΔHa and ΔHb strains (Table 1). These strains were
able to grow on SD-ura agar plates, where expression of
CaNIK1ΔHAMP was not induced. Surprisingly no growth
was observed on SG-ura plates, where galactose induced
the expression of CaNIK1ΔHAMP (Figure 4). This indi-
cated that the presence of CaNIK1ΔHAMP had inhibitory
effects on the growth of the S. cerevisiae transformant,
Figure 3 Hog1p phosphorylation after fludioxonil treatment
was dependent on the functionality of conserved domains of
CaNik1p. The phosphorylation of Hog1p (upper panel, Hog1-P) was
detected by Western blot after treatment of the strains YES, NIK,
N627, D924 and H510 with fludioxonil (10 μg/ml) and sorbitol (1 M),
respectively, for 15 min. The presence of Hog1p in all strains was
proven (lower panel, Hog1). Hog1p appeared at
approximately 50 kDa.
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did not affect growth of the transformed strain ΔH3H4
[25] (Figure 4A). Simultaneous inactivation of the HisKA
domain by the H510Q point mutation restored normalFigure 4 CaNIK1ΔHAMP expression led to growth inhibition that was
Strains BWG1-7a, YES, NIK, ΔHa, ΔHaH510 and ΔH3H4 were streaked on SD
BWG1-7a was the parent strain which is auxotrophic for uracil. (B) Strains B
streaked on SD-ura and SG-ura agar plates and incubated at 30°C for 4 day
which is auxotrophic for uracil. SG-ura medium induced the expression ofgrowth of the resultant transformed strains ΔHaH510 and
ΔHbH510 (Figure 4).
Limitation of Hog1p activity is essential for the survival
of S. cerevisiae even under normal growth conditions, as a
constitutively active MAP2K Pbs2p, which leads to consti-
tutive activation of Hog1p, is toxic [45]. Thus, we assumed
that constitutive activation of Hog1p could be the reason
for the growth inhibitory phenotype resulting from the ex-
pression of CaNIK1ΔHAMP. Therefore, S. cerevisiae strains
with single gene deletions in the response regulator SSK1
(strain Δssk1) or components of the Hog1p MAPK module,
namely the MAP2K PBS2 (strain Δpbs2) and the MAPK
HOG1 (strain Δhog), were transformed with the plasmid
pYES2-CaNIK1ΔHAMP. These transformants showed nor-
mal growth on SG-ura plates (Figure 4B), proving that the
growth inhibitory effect associated with the expression of
CaNIK1ΔHAMP was dependent on the functionality of the
HOG pathway.
Expression of CaNIK1ΔHAMP resulted in constitutive
phosphorylation of Hog1p that was dependent on the
conserved phosphate-accepting histidine residue
To further analyze the involvement of Hog1p activity, the
phosphorylation state of Hog1p was investigated. Due to
the growth inhibitory effect resulting from the expression
of CaNIK1ΔHAMP, the transformant strain ΔHa was first
cultivated on the glucose-containing medium SD-ura that
does not induce CaNIK1ΔHAMP expression to produce
sufficient biomass for protein analysis. Subsequently, the
expression of CaNIK1ΔHAMP was induced by incubating
the cells in the galactose-containing medium SG-ura. Genedependent on His510 (A) and a functional HOG pathway (B). (A)
-ura and SG-ura agar plates and incubated at 30°C for 4 days. Strain
Y4741, ΔHbΔhog, ΔHbΔpbs2, ΔHbΔssk1, ΔHbH510 and ΔHb were
s. BY4741 was the parent strain of the single gene deletion mutants,
the transgenes via the galactose promoter.
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before fludioxonil was added. Presence of CaNik1pΔHAMP
was confirmed by Western blot using an anti-FLAG–anti-
body (see Additional file 1). Phosphorylation of Hog1p was
examined after an additional 15 and 30 min (in total
195 min and 210 min respectively) (Figure 5). After
fludioxonil treatment, phosphorylation of Hog1p was
observed in the transformant strain NIK1 carrying the
full-length protein, and in the transformant strain ΔHa,
whereas no phosphorylation was detected in the strains
with the empty plasmid (YES) and with the additional
H510Q mutation (ΔHaH510), respectively. Hog1p was
phosphorylated in the transformant strain ΔHa even
without the presence of fludioxonil, while such consti-
tutive phosphorylation was not observed in the strains
NIK and ΔHaH510 (Figure 5). Thus, deletion of all
HAMP domains from CaNik1p led to constitutive acti-
vation of Hog1p without any further external stimulus,
which appears to be the reason for the growth inhibi-
tory phenotype of the transformant strain ΔHa in
galactose-containing medium.Discussion
We previously showed that expression of the group III HK
from the human fungal pathogen C. albicans, CaNIK1 in
S. cerevisiae resulted in susceptibility of the transformants
to the fungicides fludioxonil, iprodione and ambruticin
VS3 [25]. Moreover, the fungicidal activity was decreased
by deletion of single or double pairs of the N-terminal
HAMP domains [25]. For other group III HKs it was
already shown that mutations in the conserved phosphate-
accepting residues and partial deletion of the HAMP
domains conferred fungicide resistance [23,26]. This stimu-
lated our interest to investigate the involvement of the
HisKA, HATPase_c and REC domains from CaNik1p in
the fungicide activity, as they are conserved in all HKs.Figure 5 The MAPK Hog1p was constitutively phosphorylated
after expression of CaNIK1ΔHAMP in the strain ΔHa.
Phosphorylation of Hog1p (upper panel, Hog1-P) in the strains YES,
NIK, ΔHa and ΔHaH510 was detected after cultivation of the strains
in SG-ura for 195 and 210 min. Fludioxonil was added after 180 min
at a final concentration of 10 μg/ml. The presence of Hog1p (lower
panel, Hog1) was confirmed in all strains. Hog1p appears at
approximately 50 kDa.To prevent the primary phosphorylation of the histidine
residue and the subsequent His-Asp phosphate-transfer
from the HisKA to the REC domains, respectively, the
point mutations H510Q and D924N were introduced. The
N627D mutation was supposed to inactivate the ATP
binding site. The complete resistance of the strains H510
and D924 and the reduced susceptibility of the strain
N627 in comparison to the strain NIK clearly showed that
the functionalities of the above mentioned domains were
essential for the susceptibility of the transformed yeast to
the tested fungicides. In agreement, similar patterns of
Hog1p phosphorylation were obtained after treating
the different S. cerevisiae transformants with fludioxonil.
Phosphorylation of Hog1p was totally abolished in the
strains H510 and D924 and partially inhibited in the strain
N627, while in all strains expressing genes with point mu-
tations Hog1p was phosphorylated in response to osmotic
stress, but was not phosphorylated without external stim-
uli. These results are in agreement with earlier reports
of reduced antifungal susceptibilities of strains, which
expressed other group III HKs carrying point mutations in
the HisKA and REC domains [26,27]. However, the correl-
ation between the functionality of conserved HisKA, REC
and HATPase_c domains of CaNik1p and both the fungi-
cidal sensitivity and phosphorylation of Hog1p after fungi-
cidal treatment was not shown before. Altogether, we
present clear evidences that the histidine kinase function-
ality of CaNik1p was essential for the fungicidal effect and
that this effect correlated with the activation of the MAPK
Hog1p after treatment with fungicides.
The yeast histidine kinase Sln1p (group VI histidine
kinase) is a negative regulator of the MAPK Hog1p, as
its inhibition leads to activation of the MAPK. However,
for group III HKs different effects were reported: Dic1p,
the group III HK from Cochliobolus heterostrophus, was
described as a positive regulator of Hog1p [24], whereas
DhNik1p from Dabaryomyces hansenii was identified as
a negative regulator [23]. To the best of our knowledge
the relationship between the activity of CaNik1p and
Hog1p has not yet been investigated, but can now be in-
directly deduced from our data. It is generally accepted
that activation of Hog1p in the absence of osmotic stress
results in growth inhibitory effects [46]. Previously we
reported that the antifungal effects of fludioxonil, iprodione
and ambruticin VS3 are dependent on the Ssk1 - Pbs2 -
Hog1p branch of the osmotic stress response pathway [25],
so that a prerequisite for phosphorylation of Hog1p is the
non-phosphorylated form of the response regulator Ssk1p
[47]. It was even reported that the presence of phosphory-
lated Ssk1p prevented the activation of the MAP3K Ssk2p
from unphosphorylated Ssk1p [48]. Ssk1p receives phos-
phate groups indirectly from HKs via the histidine transfer
protein Ypd1p. Our results indicate that this phosphoryl-
ation is inhibited only in strains which are exposed to
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ants and are treated with fungicides. In strains expressing
mutated non-functional CaNIK1 phosphorylation of Ssk1
was not inhibited. This conclusion is in agreement with
[23] who showed that fludioxonil treatment of S. cerevisiae
expressing the group III DhNik1p decreased the phosphate
transfer to a response regulator even in the presence of the
endogenous, active HK Sln1.
Group III HKs are characterized by an amino acid re-
peat domain with five to six amino acid repeats, in each of
which a single HAMP domain was identified previously,
but which are now known to comprise concatenated pairs
of HAMP domains [25,32,33]. The function of these do-
mains is not yet clear, even though involvement in fungi-
cide susceptibility and in osmosensing were suggested
[19,23,25,37]. Previous heterologous expression of trun-
cated proteins, in which several HAMP domains were de-
leted from group III HKs, i.e. from CaNik1p [25] and
DhNik1p from D. hansenii [37], was not reported to result
in inhibition of growth of the respective S. cerevisiae
transformants. Whereas in the previous reports only se-
lected HAMP domains were deleted, here we deleted all
HAMP domains from CaNik1p (CaNik1pΔHAMP) and
observed that the synthesis of this truncated protein in the
transformed S. cerevisiae strain was associated with severe
growth inhibition. This phenotype could be reversed by
additional point mutation in the histidine phosphorylation
site of the HisKA domain (H510) or by the expression of
CaNIK1ΔHAMP in single gene deletion mutants of the re-
sponse regulator SSK1 or of one of the components of the
Hog1 module namely the MAP2K PBS2 and the MAPK
HOG1. This proved that the inhibition of growth of the
transformant upon expression of CaNIK1ΔHAMP was
dependent on the functionality of both the histidine kinase
activity of CaNik1p and the functionality of the Ssk1 -
Pbs2 - Hog1 branch of the HOG pathway. We could also
unambiguously show that the inhibited growth of the
strain ΔHa expressing CaNIK1ΔHAMP correlated with
the constitutive phosphorylation of Hog1p without any
external stimulation, which was also abolished after mu-
tation of the conserved phosphate-accepting histidine
residue (CaNIK1ΔHAMP(H510Q)). By analogy to the
previous discussion this leads to the conclusion that the
expression of CaNIK1ΔHAMP decreased the phosphate
transfer activity to Ssk1, whereas the presence of the
mutant CaNik1pΔHAMP(H510Q), which cannot be
phosphorylated on the conserved histidine residue, did
not affect the endogenous phosphorylation state of the
Ssk1p. Thus, in summary, deletion of all HAMP do-
mains had the same effect on the phosphate transfer
activity to Ssk1p as treatment with fungicides. Addition-
ally, the presence of mutated proteins, which are as-
sumed not to possess histidine kinase activity and thus
are not phosphorylated on either histidine in the HisKAdomain or on aspartate in the REC domain, did not in-
hibit growth of the transformants and did not activate
the Hog1p MAPK module. As a consequence of these
results, it seems to be unlikely that in the transformed
S. cerevisiae strains the histidine kinase activity of
CaNik1p was inhibited by fungicide treatment, because
inhibition of the kinase activity will lead to an enrich-
ment of the non-phosphorylated form of the protein,
similar to the protein variants carrying point mutations.
The mutated proteins, however, did not influence
growth whereas fungicide treatment did. Thus, our re-
sults support a model, in which the wild-type CaNik1p
protein is not phosphorylated without external stimuli,
and Ssk1p is kept in a phosphorylated form via indirect
phosphate transfer from Sln1p. Upon deletion of all
HAMP domains from CaNik1p or fungicide treatment
CaNik1p is phosphorylated and this form prevents
phosphate transfer to Ssk1p (Figure 6).
However, this model is based on the assumption that
the phosphorylation state of the endogenous histidine
kinase Sln1p is not changed by the presence of
CaNik1p, since Sln1p is a transmembrane protein that
undergoes autophosphorylation in the absence of os-
motic stress and CaNik1p is a cystosolic protein. Thus,
we expected that CaNik1p does not interfere with the
autophosphorylation of the transmembrane protein
Sln1p but with the phosphate transfer from Sln1p to
Ypd1p. But it may also be hypothesized that when
CaNik1p is phosphorylated, either following fungicide
exposure or due to the absence of regulatory HAMP
domains, Sln1p is no longer phosphorylated leading to
the accumulation of non-phosphorylated forms of
Ypd1p and Ssk1p and, hence, to the activation of
Hog1p.
Thus, CaNik1p has to be considered as a positive
regulator of Hog1p activity, similar to Dic1p from C.
heterostrophus and contrary to DhNik1p and Sln1p.
This is in agreement with the earlier results that
CaNik1p cannot reverse the lethal phenotype of Sln1
deletion in S. cerevisiae whereas DhNik1p can. How-
ever, the mechanism leading to the reduced overall
phosphate transfer activity to the response regulator re-
mains to be investigated. As long as no protein struc-
tures are available from group III histidine kinases, one
cannot exclude that point mutations and protein trun-
cation have severe effects on the protein structures.
The constructed mutated versions of CaNIK1 could
not be re-integrated in the available CaNIK1 homozy-
gous deletion mutants of Candida albicans [8-18] as
these mutants were constructed with the widely used
URA blaster method and, thus, are prototrophic for
uracil. Consequently direct transformation with the
pYES2 vectors that harbor the mutated variants of the
CaNIK1 was not possible as the vector contains URA3
Figure 6 Model of the activation of the HOG pathway via CaNIK1 or CaNIK1ΔHAMP, which were heterologously expressed in S.
cerevisiae. In scheme A, the initial situation is shown resulting from expression of CaNik1p in S. cerevisiae. In scheme B, results from fungicide
treatment of transformants expressing CaNik1p with point mutations in the conserved domains of histidine kinases were taken into consideration.
In scheme C, the growth inhibition and the constitutive Hog1 phosphorylation in transformants, in which CaNIK1ΔHAMP was expressed,
were considered.
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zygous deletion mutant has to be constructed using for
example the SAT1 flipper cassette that makes use of
nourseothricin as an antibiotic selection marker. This
will allow reintegration of the CaNIK1-mutated vari-
ants from this study in such mutant.
Conclusion
Our results show that functional HisKA, HATPase_c
and REC domains of CaNik1p are essential for the
antifungal activity of the selected agents activating
the HOG pathway. Moreover, the expression of
CaNIK1ΔHAMP in transformed S. cerevisiae was asso-
ciated with growth inhibition via constitutive phos-
phorylation of the MAPK Hog1p. In S. cerevisiae
transformed with CaNIK1, growth inhibition resulting
from treatment with the selected antifungals or from
deletion of all HAMP domains from the protein re-
quired both a functional histidine kinase CaNik1p and
an intact HOG pathway.Additional file
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